The 43rd San Antonio Breast Cancer Symposium will be one of a kind thanks to a pandemic, but the great content, information, and expert presentations you have come to expect will still come standard.
Content for this year’s event includes the relatively new Oxford-style debate and the mini-symposia.
The topic of this year’s debate is “All breast cancer patients should have germline genetic testing.” Mark Robson, MD of Memorial Sloan Kettering Cancer Center in New York will argue for the topic. Susan Domchek, MD of the University of Pennsylvania, Philadelphia, will argue against. Judy E. Garber, MD, MPH of the Dana-Farber Cancer Institute in Boston will moderate.
In an Oxford-style debate, the audience is polled regarding its position on the topic. There is another poll at the end of the debate to see who was most persuasive.
The debate will be Friday, Dec. 11 from 11:30 a.m. to 12:30 p.m. Central Standard Time (GMT -06:00).
Breast cancer prevention and its mutation will be the topics of the two mini-symposia scheduled during #SABCS20.
Katherine Crew, MD, MSc of Columbia University in New York will moderate “Recent advances in breast cancer prevention.” Her speakers will be:
- Melinda Irwin, MD, MPH, PhD of Yale University in New Haven, Connecticut presenting, “Is it time to implement lifestyle interventions in the oncology clinic”
- Constance Lehman, MD, PhD of Massachusetts General Hospital in Boston presenting, “What else is in the imaging: How AI can improve mammograms”
- Powel Brown, MD, PhD of UT MD Anderson Cancer Center in Houston presenting “Beyond hormones: Newer pharmacologic approaches”
Douglas Yee, MD of the Masonic Cancer Center at the University of Minnesota in Minneapolis will moderate the other mini-symposium, “Mechanisms of mutagenesis in breast cancer.” His speakers will be:
- Mike Stratton, FMedSci, FRS of the Wellcome Sanger Institute in Hinxton, United Kingdom presenting “Aging”
- Andrew Tutt, MB CHB, PhD of the Institute of Cancer Research, London presenting “BRCA/HRD”
- Reuben Harris, PhD of the Howard Hughes Medical Institute at the University of Minnesota in Minneapolis presenting “APOBEC”
The mini-symposia will be pre-recorded and available on demand. Their first availability will be Wednesday, Dec. 9 at 8 a.m. CST (GMT -06:00).
Registration is still open at a discounted rate from previous years. If cost or travel prohibited you from attending before, this is your best chance to hear the latest information from the leading clinicians and researchers in breast cancer research and treatment. Visit sabcs.org to register.